These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22784315)

  • 1. The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII.
    Lapalud P; Ali T; Cayzac C; Mathieu-Dupas E; Levesque H; Pfeiffer C; Balicchi J; Gruel Y; Borg JY; Schved JF; Granier C; Lavigne-Lissalde G
    J Thromb Haemost; 2012 Sep; 10(9):1814-22. PubMed ID: 22784315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.
    Sanges S; Jeanpierre E; Lopez B; Russick J; Delignat S; Carpentier B; Dubois R; Dubucquoi S; Guerrier T; Hachulla É; Hatron PY; Paris C; Susen S; Launay D; Lacroix-Desmazes S; Terriou L
    Front Immunol; 2020; 11():558811. PubMed ID: 33424828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors.
    Bonnefoy A; Merlen C; Dubé E; Claus-Desbonnet H; Rivard GE; St-Louis J
    J Thromb Haemost; 2021 Dec; 19(12):2947-2956. PubMed ID: 34455699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
    Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
    Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?
    Mahendra A; Padiolleau-Lefevre S; Kaveri SV; Lacroix-Desmazes S
    Br J Haematol; 2012 Jan; 156(1):3-12. PubMed ID: 21988190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study.
    Tiede A; Hofbauer CJ; Werwitzke S; Knöbl P; Gottstein S; Scharf RE; Heinz J; Groß J; Holstein K; Dobbelstein C; Scheiflinger F; Koch A; Reipert BM
    Blood; 2016 May; 127(19):2289-97. PubMed ID: 26912467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Jacquemin M; Krause M; Tiede A; Schwabe D; Lollar P; Königs C
    Blood; 2017 Aug; 130(6):808-816. PubMed ID: 28507083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first case of postpartum acquired hemophilia A in Korea.
    Lee JH; Kim DH; Yoo K; Choi Y; Kim SH; Kim HJ
    J Korean Med Sci; 2011 Sep; 26(9):1247-9. PubMed ID: 21935285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
    Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
    Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
    Matsumoto T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
    Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.